Market Overview:
The global clinical diagnostics PCR market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, cancer, and cardiovascular diseases; rising demand for early diagnosis and treatment; and technological advancements in PCR-based diagnostic tests. Based on type, the global clinical diagnostics PCR market is segmented into infectious disease, cancer, cardiovascular disease, genetic disorder, and other applications. The infectious disease segment is expected to account for the largest share of the global clinical diagnostics PCR market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. This growth can be attributed to increasing incidence of infections across the globe and growing demand for early diagnosis and treatment of infections.
Product Definition:
PCR stands for polymerase chain reaction. It is a laboratory technique used to amplify specific DNA sequences. PCR can be used to detect the presence of a particular gene or DNA sequence in a sample of tissue or blood. This technology is important for diagnosing genetic diseases and infections.
Infectious Disease:
Infectious diseases are those which are caused by pathogens, germs or bacteria. These microorganisms cause disease in humans and other animals. Infectious diseases can be passed from one person to another through contact with an infected wound or saliva of an infected person (contagion). Some common infectious agents include the flu virus, HIV virus, hepatitis B & C and Human Papillomavirus (HPV).
Cancer:
The global cancer and it's usage in clinical diagnostics PCR market size was valued at USD 4.8 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period on account of rising prevalence of cancer worldwide coupled with increasing demand for early diagnostic techniques.
Application Insights:
The hospitals segment dominated the global clinical diagnostics PCR market in 2017. Hospitals and clinics are the primary users of these tests as they can detect a wide range of infectious diseases, cancer, and genetic disorders with high specificity and sensitivity. The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes mellitus type 2 & 3, autoimmune disease & respiratory infections is expected to drive demand for these devices in hospitals and clinics over the forecast period.
Increasing investments by governments to improve healthcare infrastructure have led to an increase in hospital construction across the globe. For instance, according to WHO data published in 2018; total investment needed for health infrastructure development globally was estimated at USD 300 billion annually from 2016 to 2030. An increase of around USD 150 billion was required annually from 2016 to 2030 which represented 11% of total investment needed during that period (excluding reinvestments).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of advanced healthcare facilities. In addition, rising prevalence of chronic diseases such as cancer and cardiovascular disorders is expected to drive demand for PCR tests in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing government initiatives for improving healthcare infrastructure coupled with rising awareness regarding early diagnosis of infectious diseases such as HIV/AIDS & cancer.
In China and India, a large number of companies are focusing on research activities pertaining molecular diagnostics due to huge unmet needs along with rapidly growing target population base in these countries which supports regional market growth over next eight years to 2030 time frame.
Growth Factors:
- Increasing demand for early and accurate diagnosis of diseases
- Rising prevalence of infectious diseases
- Technological advancements in PCR assay development
- Growing number of private diagnostic laboratories
- Increasing awareness about the benefits of molecular diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Diagnostics PCR Market Research Report
By Type
Infectious Disease, Cancer, Cardiovascular, Genetic, Others
By Application
Hospitals, Clinics, Others
By Companies
Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biomérieux, Bio-Rad Laboratories, Inc., Genmark Diagnostics, Inc., Hologic, Inc., Luminex Corporation, Meridian Bioscience, Inc., Qiagen N.V., Quantumdx Group, Quidel, Inc., Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Diagnostics PCR Market Report Segments:
The global Clinical Diagnostics PCR market is segmented on the basis of:
Types
Infectious Disease, Cancer, Cardiovascular, Genetic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies Inc.
- Abbott
- Asuragen, Inc.
- Danaher
- Biocartis Group Nv
- Biomérieux
- Bio-Rad Laboratories, Inc.
- Genmark Diagnostics, Inc.
- Hologic, Inc.
- Luminex Corporation
- Meridian Bioscience, Inc.
- Qiagen N.V.
- Quantumdx Group
- Quidel, Inc.
- Roche
Highlights of The Clinical Diagnostics PCR Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infectious Disease
- Cancer
- Cardiovascular
- Genetic
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Diagnostics PCR Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical diagnostics PCR (also known as C-PCR) is a molecular diagnostic technique that uses PCR to amplify specific DNA sequences from clinical specimens. This technology can be used to identify various types of cancer, including lung, ovarian, and pancreatic cancers.
Some of the major players in the clinical diagnostics pcr market are Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biom©rieux, Bio-Rad Laboratories, Inc., Genmark Diagnostics, Inc., Hologic, Inc., Luminex Corporation, Meridian Bioscience, Inc., Qiagen N.V., Quantumdx Group, Quidel, Inc., Roche.
The clinical diagnostics pcr market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Diagnostics PCR Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Diagnostics PCR Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Diagnostics PCR Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Diagnostics PCR Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Diagnostics PCR Market Size & Forecast, 2018-2028
4.5.1 Clinical Diagnostics PCR Market Size and Y-o-Y Growth
4.5.2 Clinical Diagnostics PCR Market Absolute $ Opportunity
Chapter 5 Global Clinical Diagnostics PCR Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Diagnostics PCR Market Size Forecast by Type
5.2.1 Infectious Disease
5.2.2 Cancer
5.2.3 Cardiovascular
5.2.4 Genetic
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Diagnostics PCR Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Diagnostics PCR Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Diagnostics PCR Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Diagnostics PCR Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Diagnostics PCR Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Diagnostics PCR Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Diagnostics PCR Market Size Forecast by Type
9.6.1 Infectious Disease
9.6.2 Cancer
9.6.3 Cardiovascular
9.6.4 Genetic
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Diagnostics PCR Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Diagnostics PCR Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Diagnostics PCR Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Diagnostics PCR Market Size Forecast by Type
10.6.1 Infectious Disease
10.6.2 Cancer
10.6.3 Cardiovascular
10.6.4 Genetic
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Diagnostics PCR Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Diagnostics PCR Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Diagnostics PCR Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Diagnostics PCR Market Size Forecast by Type
11.6.1 Infectious Disease
11.6.2 Cancer
11.6.3 Cardiovascular
11.6.4 Genetic
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Diagnostics PCR Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Diagnostics PCR Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Diagnostics PCR Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Diagnostics PCR Market Size Forecast by Type
12.6.1 Infectious Disease
12.6.2 Cancer
12.6.3 Cardiovascular
12.6.4 Genetic
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Diagnostics PCR Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Diagnostics PCR Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Diagnostics PCR Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Diagnostics PCR Market Size Forecast by Type
13.6.1 Infectious Disease
13.6.2 Cancer
13.6.3 Cardiovascular
13.6.4 Genetic
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Diagnostics PCR Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Diagnostics PCR Market: Competitive Dashboard
14.2 Global Clinical Diagnostics PCR Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Agilent Technologies Inc.
14.3.3 Abbott
14.3.4 Asuragen, Inc.
14.3.5 Danaher
14.3.6 Biocartis Group Nv
14.3.7 Biomérieux
14.3.8 Bio-Rad Laboratories, Inc.
14.3.9 Genmark Diagnostics, Inc.
14.3.10 Hologic, Inc.
14.3.11 Luminex Corporation
14.3.12 Meridian Bioscience, Inc.
14.3.13 Qiagen N.V.
14.3.14 Quantumdx Group
14.3.15 Quidel, Inc.
14.3.16 Roche
